Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBP510 Booster Vaccination Study
NCT05175950Phase 2Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- Jan 2022
- Primary completion
- Aug 2023
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GBP510 + AS03 in coronavirus disease 2019 (COVID-19), sponsored by Korea University Guro Hospital. Status: unknown.
02
Drugs
GBP510 + AS03
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05175950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05175950.